Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B

doi:10.4254/wjh.v18.i2.114346

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-4)

Sum=17

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Feb 27, 2026 (publication date) through Feb 12, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Feb 27, 2026; 18(2): 114346
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.114346

Open in New Tab Full Size Figure Download Figure

Figure 1 Study flow chart. CHB: Chronic hepatitis B; ETV: Entecavir; TMF: Tenofovir amibufenamide; TAF: Tenofovir alafenamide; TDF: Tenofovir disoproxil fumarate; HIV: Human immunodeficiency virus.

Open in New Tab Full Size Figure Download Figure

Figure 2 Receiver operating characteristic curves. A: Baseline estimated glomerular filtration rate; B: Triglyceride.

Open in New Tab Full Size Figure Download Figure

Figure 3 Dynamic changes and extent of decline in estimated glomerular filtration rate. A: Dynamic changes over time; B: Extent of decline. eGFR: Estimated glomerular filtration rate; ETV: Entecavir; TMF: Tenofovir amibufenamide.

Citation: Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF. Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. World J Hepatol 2026; 18(2): 114346
URL: https://www.wjgnet.com/1948-5182/full/v18/i2/114346.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i2.114346